Ocular surface inflammation mediated by innate immunity

Eye and Contact Lens

Volumn 36, Issue 5, 2010, Pages 269-281

  Ueta, Mayumi ^a,b   Kinoshita, Shigeru ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b DOSHISHA UNIVERSITY   (Japan)

Author keywords

Epithelium; Innate immunity; Ocular surface; Stevens Johnson Syndrome; Toll like receptors

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; LIPOPOLYSACCHARIDE; MESSENGER RNA; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

ALLERGIC CONJUNCTIVITIS; ANKYLOBLEPHARON; APOPTOSIS; BLISTER; CELL LOSS; CELL SURFACE; COMMENSAL; DRY EYE; EOSINOPHIL; EPITHELIUM CELL; EROSION; EYE ALLERGY; EYE INFLAMMATION; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC PREDISPOSITION; GOBLET CELL; HUMAN; IMMUNOPATHOLOGY; INNATE IMMUNITY; KERATITIS; KNOCKOUT MOUSE; MACROPHAGE; MAST CELL; NONHUMAN; ORAL BLEEDING; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STAPHYLOCOCCUS EPIDERMIDIS; STEVENS JOHNSON SYNDROME; SYMBLEPHARON; TRICHIASIS;

ANIMALS; CONJUNCTIVITIS; FAS LIGAND PROTEIN; GENE EXPRESSION; GOBLET CELLS; HUMANS; I-KAPPA B PROTEINS; IMMUNITY, INNATE; INTERLEUKIN-1ALPHA; KERATITIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN ISOFORMS; RECEPTORS, INTERLEUKIN-4; RNA, MESSENGER; STEVENS-JOHNSON SYNDROME; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTORS;

EID: 77957563358     PISSN: 15422321     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICL.0b013e3181ee8971     Document Type: Review

References (51)

1. Ueta M, Iida T, Sakamoto M., et al. Polyclonality of Staphylococcus epidermidis residing on the healthy ocular surface. J Med Microbiol 2007; 56: 77-82.
2. Akira S. Toll-like receptor signaling. J Biol Chem 2003; 278: 38105-38108.
3. Rakoff-Nahoum S., Paglino J, Eslami-Varzaneh F, et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118: 229-241.
4. Ueta M. Innate immunity of the ocular surface and ocular surface inflammatory disorders. Cornea 2008; 27(SUPPL. 1): S31-S40.
5. Ueta M, Kinoshita S. Innate immunity of the ocular surface. Brain Res Bull 2010; 81: 219-228.
6. Ueta M, Nochi T, Jang M.H., et al. Intracellularly expressed TLR2s and TLR4s contribution to an immunosilent environment at the ocular mucosal epithelium. J Immunol 2004; 173: 3337-3347.
7. Kojima K, Ueta M, Hamuro J., et al. Human conjunctival epithelial cells express functional Toll-like receptor 5. Br J Ophthalmol 2008; 92: 411-416.
8. Ueta M, Hamuro J, Kiyono H., et al. Triggering of TLR3 by polyI: C in human corneal epithelial cells to induce inflammatory cytokines. Biochem Biophys Res Commun 2005; 331: 285-294.
9. Kleinman ME, Yamada K, Takeda A., et al. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 2008; 452: 591-597.
10. Matsumoto M, Kikkawa S, Kohase M., et al. Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem Biophys Res Commun 2002; 293: 1364-1369.
11. Uematsu S, Akira S. Toll-like receptors and Type I interferons. J Biol Chem 2007; 282: 15319-15323.
12. Hozono Y, Ueta M, Hamuro J., et al. Human corneal epithelial cells respond to ocular-pathogenic, but not to nonpathogenic-flagellin. Biochem Biophys Res Commun 2006; 347: 238-247.
13. Alexopoulou L, Holt AC, Medzhitov R, et al. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001; 413: 732-738.
14. Ueta M, Matsuoka T, Narumiya S., et al. Prostaglandin E receptor subtype EP3 in conjunctival epithelium regulates late-phase reaction of experimental allergic conjunctivitis. J Allergy Clin Immunol 2009; 123: 466-471.
15. Ueta M, Nakamura T, Tanaka S., et al. Development of eosinophilic conjunctival inflammation at late-phase reaction in mast cell-deficient mice. J Allergy Clin Immunol 2007; 120: 476-478.
16. Ueta M, Mizushima K, Yokoi N., et al. Gene expression analysis of polyI: C-stimulated primary human conjunctival epithelial cells [published online ahead of print July 23, 2010]. Br J Ophthalmol doi:10.1136/bjo.2010.180554.
17. Harvey SA, Romanowski EG, Yates K.A., et al. Adenovirus-directed ocular innate immunity: The role of conjunctival defensin-like chemokines (IP-10, I-TAC) and phagocytic human defensin-alpha. Invest Ophthalmol Vis Sci 2005; 46: 3657-3665.
18. Klunker S, Trautmann A, Akdis M., et al. A second step of chemotaxis after transendothelial migration: Keratinocytes undergoing apoptosis release IFN-gamma-inducible protein 10, monokine induced by IFN-gamma, and IFN-gamma-inducible alpha-chemoattractant for T cell chemotaxis toward epidermis in atopic dermatitis. J Immunol 2003; 171: 1078-1084.
19. Ying S, O'Connor B, Ratoff J, et al. Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease. J Immunol 2008; 181: 2790-2798.
20. Bullens DM, Decraene A, Dilissen E., et al. Type III IFN-lambda mRNA expression in sputum of adult and school-aged asthmatics. Clin Exp Allergy 2008; 38: 1459-1467.
21. Kotenko SV, Gallagher G, Baurin V.V., et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 2003; 4: 69-77.
22. Gros E, Bussmann C, Bieber T., et al. Expression of chemokines and chemokine receptors in lesional and nonlesional upper skin of patients with atopic dermatitis. J Allergy Clin Immunol 2009; 124: 753-760.
23. Prehaud C, Megret F, Lafage M., et al. Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon. J Virol 2005; 79: 12893-12904.
24. Ziegler SF, Liu YJ Thymic stromal lymphopoietin in normal and pathogenic T cell development and function. Nat Immunol 2006; 7: 709-714.
25. Soumelis V, Reche PA, Kanzler H, et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002; 3: 673-680.
26. Ying S, O'Connor B, Ratoff J, et al. Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J Immunol 2005; 174: 8183-8190.
27. Hingorani M, Calder VL, Buckley R.J., et al. The role of conjunctival epithelial cells in chronic ocular allergic disease. Exp Eye Res 1998; 67: 491-500.
28. Yamazaki S, Muta T, Takeshige K. A novel IkappaB protein, IkappaB-zeta, induced by proinflammatory stimuli, negatively regulates nuclear factor-kappaB in the nuclei. J Biol Chem 2001; 276: 27657-27662.
29. Yamamoto M, Yamazaki S, Uematsu S., et al. Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein Ikap-paBzeta. Nature 2004; 430: 218-222.
30. Ueta M, Hamuro J, Yamamoto M., et al. Spontaneous ocular surface inflammation and goblet cell disappearance in I kappa B zeta gene-disrupted mice. Invest Ophthalmol Vis Sci 2005; 46: 579-588.
31. Ueta M, Hamuro J, Ueda E., et al. Stat6-independent tissue inflammation occurs selectively on the ocular surface and perioral skin of IkappaBzeta-/-mice. Invest Ophthalmol Vis Sci 2008; 49: 3387-3394.
32. Ueta M, Sotozono C, Inatomi T., et al. Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndrome. Br J Ophthalmol 2007; 91: 962-965.
33. Yetiv JZ, Bianchine JR, Owen JA Jr. Etiologic factors of the StevensJohnson syndrome. South Med J 1980; 73: 599-602.
34. Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995; 333: 1600-1607.
35. Sotozono C, Ueta M, Koizumi N., et al. Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications. Ophthalmology 2009; 116: 685-690.
36. Araki Y, Sotozono C, Inatomi T., et al. Successful treatment of StevensJohnson syndrome with steroid pulse therapy at disease onset. Am J Ophthalmol 2009; 147: 1004-1011, 1011.e1.
37. Sotozono C, Ang LP, Koizumi N, et al. New grading system for the evaluation of chronic ocular manifestations in patients with Stevens-Johnson syndrome. Ophthalmology 2007; 114: 1294-1302.
38. Sotozono C, Inagaki K, Fujita A., et al. Methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus epidermidis infections in the cornea. Cornea 2002; 21(7 SUPPL.): S94-S101.
39. Ueta M, Sotozono C, Inatomi T., et al. Association of IL4R polymorphisms with Stevens-Johnson syndrome. J Allergy Clin Immunol 2007; 120: 1457-1459.
40. Correia O, Delgado L, Roujeau J.C., et al. Soluble interleukin 2 receptor and interleukin 1alpha in toxic epidermal necrolysis: A comparative analysis of serum and blister fluid samples. Arch Dermatol 2002; 138: 29-32.
41. Ueta M, Sotozono C, Inatomi T., et al. Association of combined IL-13/IL-4R signaling pathway gene polymorphism with Stevens-Johnson syndrome accompanied by ocular surface complications. Invest Ophthalmol Vis Sci 2008; 49: 1809-1813.
42. Ueta M, Sotozono C, Inatomi T., et al. Association of Fas Ligand gene polymorphism with Stevens-Johnson syndrome. Br J Ophthalmol 2008; 92: 989-991.
43. Heinzmann A, Mao XQ, Akaiwa M, et al. Genetic variants of IL-13 signalling and human asthma and atopy. Hum Mol Genet 2000; 9: 549-559.
44. *0206 and Stevens-Johnson syndrome in the Japanese. Am J Ophthalmol 2007; 143: 367-368. (Pubitemid 46136149)
45. Ueta M, Tokunaga K, Sotozono C., et al. HLA class I and II gene polymorphisms in Stevens-Johnson syndrome with ocular complications in Japanese. Mol Vis 2008; 14: 550-555.
46. Mondino BJ, Brown SI, Biglan AW HLA antigens in Stevens-Johnson syndrome with ocular involvement. Arch Ophthalmol 1982; 100: 1453-1454.
47. Roujeau JC, Bracq C, Huyn N.T., et al. HLA phenotypes and bullous cutaneous reactions to drugs. Tissue Antigens 1986; 28: 251-254.
48. Roujeau JC, Huynh TN, Bracq C, et al. Genetic susceptibility to toxic epidermal necrolysis. Arch Dermatol 1987; 123: 1171-1173.
49. Tokunaga K, Ishikawa Y, Ogawa A., et al. Sequence-based association analysis of HLA class I and II alleles in Japanese supports conservation of common haplotypes. Immunogenetics 1997; 46: 199-205.
50. Power WJ, Saidman SL, Zhang D.S., et al. HLA typing in patients with ocular manifestations of Stevens-Johnson syndrome. Ophthalmology 1996; 103: 1406-1409.
51. Ueta M, Uematsu S, Akira S., et al. Toll-like receptor 3 enhances late-phase reaction of experimental allergic conjunctivitis. J Allergy Clin Immunol 2009; 123: 1187-1189.